Ck Life Sciences
Ck Life Sciences, also known as Ck Life Sciences International Holdings, is a prominent biotechnology company headquartered in Hong Kong. Founded in 2000, the company has established itself as a leader in the life sciences sector, focusing on innovative solutions in agricultural biotechnology and healthcare.
With a strong presence in Asia and expanding operations globally, Ck Life Sciences is dedicated to developing unique products that enhance crop yields and improve human health. Their core offerings include advanced biopesticides and nutraceuticals, distinguished by their commitment to sustainability and efficacy.
Recognised for its pioneering research and development, Ck Life Sciences has achieved significant milestones, positioning itself as a key player in the biotechnology industry. The company continues to drive advancements that contribute to a healthier and more sustainable future.
-10 vs industry average
Ck Life Sciences’s score of 28 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ck Life Sciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Ck Life Sciences's reported carbon emissions
In 2024, Ck Life Sciences, headquartered in Hong Kong, reported total emissions of approximately 47,495,000 kg CO2e, comprising 31,245,000 kg CO2e from Scope 1 and 16,250,000 kg CO2e from Scope 2 emissions. This reflects a slight decrease from 2023, where total emissions were approximately 48,960,000 kg CO2e, with Scope 1 emissions at 32,037,000 kg CO2e and Scope 2 at 16,923,000 kg CO2e. Ck Life Sciences has committed to achieving net-zero emissions by 2050, as outlined in their long-term reduction target initiated in 2019. This commitment encompasses all scopes of emissions, demonstrating a proactive approach to climate action. The company has not yet established Science-Based Targets Initiative (SBTi) targets but is actively working towards its climate goals. The emissions data is sourced from CK Life Sciences Int'l., (Holdings) Inc., and reflects the company's ongoing efforts to monitor and reduce its carbon footprint. As of now, there is no reported data for Scope 3 emissions, indicating potential areas for future improvement in their sustainability strategy.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ck Life Sciences’s Climate Goals (2030 & 2050)
1 goal2050
NGFS Net Zero 2050
NGFS Net Zero 2050
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Ck Life Sciences
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project